Birdwatch Note Rating
2023-03-16 22:40:48 UTC - HELPFUL
Rated by Participant: CF41A6C76B77835CE95459C309412CF694C999B2CBAE87F3FC9B9B53E2FE2677
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details